Captrust Financial Advisors raised its position in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 18.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 57,182 shares of the company's stock after buying an additional 9,012 shares during the quarter. Captrust Financial Advisors' holdings in Tempus AI were worth $1,930,000 at the end of the most recent quarter.
A number of other hedge funds also recently bought and sold shares of TEM. Operose Advisors LLC purchased a new stake in Tempus AI during the fourth quarter valued at about $25,000. Farther Finance Advisors LLC purchased a new stake in shares of Tempus AI in the fourth quarter worth approximately $34,000. Prestige Wealth Management Group LLC boosted its holdings in shares of Tempus AI by 910.4% during the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock worth $36,000 after purchasing an additional 965 shares during the period. NewEdge Advisors LLC acquired a new stake in shares of Tempus AI during the fourth quarter worth approximately $49,000. Finally, First Horizon Advisors Inc. boosted its holdings in shares of Tempus AI by 207.9% during the fourth quarter. First Horizon Advisors Inc. now owns 1,641 shares of the company's stock worth $55,000 after purchasing an additional 1,108 shares during the period. 24.22% of the stock is owned by hedge funds and other institutional investors.
Insider Activity
In related news, COO Ryan Fukushima sold 20,000 shares of the business's stock in a transaction on Tuesday, May 6th. The shares were sold at an average price of $52.36, for a total transaction of $1,047,200.00. Following the transaction, the chief operating officer now owns 884,460 shares of the company's stock, valued at approximately $46,310,325.60. The trade was a 2.21% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Wayne A.I. Frederick sold 3,000 shares of the business's stock in a transaction on Monday, March 31st. The stock was sold at an average price of $45.54, for a total transaction of $136,620.00. Following the transaction, the director now directly owns 26,514 shares in the company, valued at $1,207,447.56. This trade represents a 10.16% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 4,237,561 shares of company stock valued at $251,210,331 over the last 90 days. 27.60% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
Several research firms recently commented on TEM. Guggenheim restated a "buy" rating on shares of Tempus AI in a report on Tuesday, February 25th. Needham & Company LLC restated a "buy" rating and set a $70.00 price target on shares of Tempus AI in a report on Wednesday, May 7th. Morgan Stanley raised their price target on shares of Tempus AI from $60.00 to $65.00 and gave the stock an "overweight" rating in a report on Friday. Wolfe Research cut shares of Tempus AI from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 26th. Finally, William Blair restated a "market perform" rating on shares of Tempus AI in a report on Tuesday, February 25th. Six equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $61.50.
Check Out Our Latest Stock Report on TEM
Tempus AI Trading Up 2.2%
NASDAQ:TEM opened at $62.69 on Tuesday. Tempus AI, Inc. has a 12 month low of $22.89 and a 12 month high of $91.45. The firm has a market cap of $10.80 billion and a price-to-earnings ratio of -8.04. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The company's 50 day moving average is $48.59 and its 200-day moving average is $51.18.
Tempus AI (NASDAQ:TEM - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) EPS for the quarter, beating analysts' consensus estimates of ($0.27) by $0.03. The firm had revenue of $255.74 million during the quarter, compared to the consensus estimate of $248.13 million. Tempus AI's revenue for the quarter was up 75.4% compared to the same quarter last year. Equities analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current year.
Tempus AI Company Profile
(
Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Further Reading
Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.